Microbiome-derived metabolites as a novel approach to treat chronic lung inflammation.

A nanobody-based anti-inflammatory treatment against Pseudomonas aeruginosa-induced inflammation in chronic lung diseases.

BATTLE - Boost Antibiotics Through The Lung microbiomE

Doctoral project Gilles De Meester

Towards microbiome-based therapies to reduce inflammation in chronic airway diseases.

Analysis and prevention of microbial biofilms on medical devices and in chronic wounds.

Assessing the evolutionary robustness of anti-biofilm combination therapy.

Doctoral project Amber De Bleeckere

Doctoral project Charlotte Rigauts

Doctoral project Eva Vandeplassche

Doctoral project Ian Vandenbussche

Doctoral project Sarah Tavernier

Influence of CFTR modulator therapy on microbial behaviour in cystic fibrosis

Modulation of bacterial metabolism to potentiate antibiotic efficacy against Pseudomonas aeruginosa biofilm infections

Novel approaches for rapid detection of microorganisms in clinical and pharmaceutical microbiology

Novel insights into the antibiofilm activity of borneol, citral and their combination.

The use of genetically engineered phages to tackle polymicrobial biofilm-related infections

Accelerating the valorisation of the BEAT inflammation technology, a microbiome-based biotherapeutic for chronic respiratory inflammatory diseases.

A nanobody-based anti-inflammatory treatment against pathogen-induced chronic lung inflammation

A nanobody-based anti-inflammatory treatment against Pseudomonas aeruginosa-induced inflammation in chronic lung diseases.

A nanobody-based anti-inflammatory treatment against Pseudomonas aeruginosa-induced inflammation in chronic lung diseases

Designing anti-inflammatory probiotics to treat chronic lung inflammation.

Exploring the anti-virulence potential of the lung microbiome in chronic airway infections

Fund Alphonse & Jean Forton and the Belgian CF Association muco.be: 'BEAT Pseudomonas: Beneficial bactEria AgainsT Pseudomonas'

Research towards novel therapies against chronic lung infections

The role of host-microbiome interactions in the efficacy of antimicrobial agents

Towards novel treatments against lung diseases.

Towards the launch of BactoRelief – a spin-off company providing the first-in-class inhalation live biotherapeutic product to treat chronic airway inflammation

Cystic fibrosis as a modulable model for host – microorganism interactions in airway disease.

Democratizing High-Throughput Next Generation Sequencing across different Life Science Fields: the AVITI Next Generation Sequencer.

Equipment for establishment of a three-dimensional tissue culture facility

Pathogenesis of lymphoid follicle formation and mucosal immunity in Chronic Obstructive Pulmonary Disease

White light laser-based confocal fluorescence lifetime imaging microscope for multi-parameter 3D live imaging